Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025 2025-10-02 16:41
Lundbeck's potential treatment for Multiple System Atrophy granted Orphan Drug Designation in Japan 2025-03-10 16:57
1